AAV Particles

AAV Particles Adeno-associated virus (AAV) particles are packaged and purified viruses designed to insert transgenic material into mammalian cells. These AAV viruses are carefully produced with defined titer amounts for research applications involving gene expression, gene editing, cell line development, and gene therapy. AAV vectors generally have an insert size of up to 5 kb that can produce transient or stable gene expression. AAV also features tissue specificity based on its different capsid serotypes. Visit the supplier page for more information.

AAV Particles

Your search returned 43513 AAV Particles across 6 suppliers.
Showing 30 of 43513 products
Select up to 5 products from below to compare or request more information.
pAAV-CaMKIIa-eNpHR 3.0-EYFP (AAV9)
  • Quantity:
    100 µL
  • Description:
    CaMKIIa-driven eNpHR 3.0-EYFP for optogenetic inhibition
  • Nucleic Acid Type:
    Expression Vectors, Viral Particles
Citations:
(1)
pAAV-CaMKIIa-hChR2(E123A)-EYFP (AAV9)
  • Quantity:
    100 µL
  • Description:
    CaMKIIa-driven hChR2(E123A)-EYFP expression for optogenetic activation
  • Nucleic Acid Type:
    Expression Vectors, Viral Particles
Citations:
(2)
pAAV-CaMKIIa-hChR2(H134R)-EYFP (AAV2)
  • Quantity:
    100 µL
  • Description:
    CaMKIIa-driven, humanized channelrhodopsin H134R mutant fused to EYFP for optogenetic activation
  • Nucleic Acid Type:
    Expression Vectors, Viral Particles
Citations:
(2)
pAAV-CaMKIIa-hChR2(H134R)-EYFP (AAV5)
  • Quantity:
    100 µL
  • Description:
    CaMKIIa-driven, humanized channelrhodopsin H134R mutant fused to EYFP for optogenetic activation
  • Nucleic Acid Type:
    Expression Vectors, Viral Particles
Citations:
(17)
pAAV-CaMKIIa-hChR2(H134R)-EYFP (AAV9)
  • Quantity:
    100 µL
  • Description:
    CaMKIIa-driven, humanized channelrhodopsin H134R mutant fused to EYFP for optogenetic activation
  • Nucleic Acid Type:
    Expression Vectors, Viral Particles
Citations:
(20)
pAAV-CaMKIIa-hChR2(H134R)-mCherry (AAV5)
  • Quantity:
    100 µL
  • Description:
    CaMKIIa-driven, humanized channelrhodopsin H134R mutant fused to mCherry for optogenetic activation
  • Nucleic Acid Type:
    Expression Vectors, Viral Particles
Citations:
(4)
pAAV-CaMKIIa-hChR2(H134R)-mCherry (AAV9)
  • Quantity:
    100 µL
  • Description:
    CaMKIIa-driven, humanized channelrhodopsin H134R mutant fused to mCherry for optogenetic activation
  • Nucleic Acid Type:
    Expression Vectors, Viral Particles
Citations:
(7)
pAAV-CaMKIIa-hM3D(Gq)-mCherry (AAV5)
  • Quantity:
    100 µL
  • Description:
    CaMKIIa-driven hM3D(Gq) receptor with an mCherry reporter for CNO-induced neuronal activation
  • Nucleic Acid Type:
    Expression Vectors, Viral Particles
Citations:
(10)
pAAV-CaMKIIa-hM3D(Gq)-mCherry (AAV8)
  • Quantity:
    100 µL
  • Description:
    CaMKIIa-driven hM3D(Gq) receptor with an mCherry reporter for CNO-induced neuronal activation
  • Nucleic Acid Type:
    Expression Vectors, Viral Particles
Citations:
(11)
pAAV-CaMKIIa-hM4D(Gi)-mCherry (AAV5)
  • Quantity:
    100 µL
  • Description:
    CaMKIIa-driven hM4D(Gi) receptor with an mCherry reporter for CNO-induced neuronal silencing
  • Nucleic Acid Type:
    Expression Vectors, Viral Particles
Citations:
(20)
pAAV-CaMKIIa-hM4D(Gi)-mCherry (AAV8)
  • Quantity:
    100 µL
  • Description:
    CaMKIIa-driven hM4D(Gi) receptor with an mCherry reporter for CNO-induced neuronal silencing
  • Nucleic Acid Type:
    Expression Vectors, Viral Particles
Citations:
(19)
pAAV-CamKII-ArchT-GFP (PV2527) (AAV5)
  • Quantity:
    100 µL
  • Description:
    CaMKII-driven ArchT-GFP expression for optogenetic inhibition
  • Nucleic Acid Type:
    Expression Vectors, Viral Particles
Citations:
(2)
pAAV-EF1a-double floxed-hChR2(H134R)-EYFP-WPRE-HGHpA (AAV Retrograde)
  • Quantity:
    100 µL
  • Description:
    These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons
  • Nucleic Acid Type:
    Expression Vectors, Viral Particles
Citations:
(16)
pAAV-EF1a-double floxed-hChR2(H134R)-EYFP-WPRE-HGHpA (AAV5)
  • Quantity:
    100 µL
  • Description:
    EF1a-driven, Cre-dependent, humanized channelrhodopsin H134R mutant fused to EYFP, for optogenetic activation
  • Nucleic Acid Type:
    Expression Vectors, Viral Particles
Citations:
(61)
Figures:
(2)
pAAV-EF1a-double floxed-hChR2(H134R)-EYFP-WPRE-HGHpA (AAV9)
  • Quantity:
    100 µL
  • Description:
    EF1a-driven, Cre-dependent, humanized channelrhodopsin H134R mutant fused to EYFP, for optogenetic activation
  • Nucleic Acid Type:
    Expression Vectors, Viral Particles
Citations:
(56)
pAAV-EF1a-double floxed-hChR2(H134R)-mCherry-WPRE-HGHpA (AAV Retrograde)
  • Quantity:
    100 µL
  • Description:
    Humanized channelrhodopsin H134R mutant fused to mCherry, driven by the EF1a promoter. Cre-dependent. These AAV were produced with a retrograde ...
  • Nucleic Acid Type:
    Expression Vectors, Viral Particles
Citations:
(6)
pAAV-EF1a-double floxed-hChR2(H134R)-mCherry-WPRE-HGHpA (AAV5)
  • Quantity:
    100 µL
  • Description:
    Humanized channelrhodopsin H134R mutant fused to mCherry, driven by the EF1a promoter. Cre-dependent
  • Nucleic Acid Type:
    Expression Vectors, Viral Particles
Citations:
(18)
pAAV-EF1a-double floxed-hChR2(H134R)-mCherry-WPRE-HGHpA (AAV8)
  • Quantity:
    100 µL
  • Description:
    Humanized channelrhodopsin H134R mutant fused to mCherry, driven by the EF1a promoter. Cre-dependent
  • Nucleic Acid Type:
    Expression Vectors, Viral Particles
Citations:
(16)
pAAV-EF1a-double floxed-hChR2(H134R)-mCherry-WPRE-HGHpA (AAV9)
  • Quantity:
    100 µL
  • Description:
    Humanized channelrhodopsin H134R mutant fused to mCherry, driven by the EF1a promoter. Cre-dependent
  • Nucleic Acid Type:
    Expression Vectors, Viral Particles
Citations:
(24)
pAAV-EF1a-mCherry-IRES-Flpo (AAV Retrograde)
  • Quantity:
    100 µL
  • Description:
    Flpo and bicistronic (IRES) mCherry expression under the EF1a promoter. These AAV were produced with a retrograde serotype, which permits retrograde ...
  • Nucleic Acid Type:
    Expression Vectors, Viral Particles
Citations:
(5)
pAAV-Ef1a-DIO C1V1 (t/t)-TS-EYFP (AAV9)
  • Quantity:
    100 µL
  • Description:
    EFIa-driven, Cre-dependent, C1V1 (t/t) fused to EYFP for optogenetic activation
  • Nucleic Acid Type:
    Expression Vectors, Viral Particles
Citations:
(1)
pAAV-Ef1a-DIO C1V1 (t/t)-TS-mCherry (PV2670) (AAV9)
  • Quantity:
    100 µL
  • Description:
    EFIa-driven, Cre-dependent, C1V1 (t/t) fused to mCherry for optogenetic activation
  • Nucleic Acid Type:
    Expression Vectors, Viral Particles
Citations:
(1)
pAAV-Ef1a-DIO ChETA-EYFP (AAV5)
  • Quantity:
    100 µL
  • Description:
    EF1a-driven, Cre-dependent, ChETA fused to EYFP for optogenetic activation
  • Nucleic Acid Type:
    Expression Vectors, Viral Particles
Citations:
(3)
pAAV-Ef1a-DIO ChETA-EYFP (AAV9)
  • Quantity:
    100 µL
  • Description:
    EF1a-driven, Cre-dependent, ChETA fused to EYFP for optogenetic activation
  • Nucleic Acid Type:
    Expression Vectors, Viral Particles
Citations:
(3)
pAAV-Ef1a-DIO EYFP (AAV2)
  • Quantity:
    100 µL
  • Description:
    EF1a-driven, cre-dependent EYFP expression
  • Nucleic Acid Type:
    Expression Vectors, Viral Particles
Citations:
(8)
pAAV-Ef1a-DIO EYFP (AAV5)
  • Quantity:
    100 µL
  • Description:
    EF1a-driven, cre-dependent EYFP expression
  • Nucleic Acid Type:
    Expression Vectors, Viral Particles
Citations:
(34)
pAAV-Ef1a-DIO EYFP (AAV9)
  • Quantity:
    100 µL
  • Description:
    EF1a-driven, cre-dependent EYFP expression
  • Nucleic Acid Type:
    Expression Vectors, Viral Particles
Citations:
(18)
pAAV-Ef1a-DIO eNpHR 3.0-EYFP (AAV5)
  • Quantity:
    100 µL
  • Description:
    EF1a-driven, cre-dependent eNpHR 3.0-EYFP for optogenetic inhibition
  • Nucleic Acid Type:
    Expression Vectors, Viral Particles
Citations:
(16)
pAAV-Ef1a-DIO eNpHR 3.0-EYFP (AAV9)
  • Quantity:
    100 µL
  • Description:
    EF1a-driven, cre-dependent eNpHR 3.0-EYFP for optogenetic inhibition
  • Nucleic Acid Type:
    Expression Vectors, Viral Particles
Citations:
(15)
pAAV-Ef1a-DIO hChR2(E123T/T159C)-EYFP (AAV5)
  • Quantity:
    100 µL
  • Description:
    EF1a-driven, Cre-dependent, humanized channelrhodopsin E123T/T159C mutant fused to EYFP for optogenetic activation
  • Nucleic Acid Type:
    Expression Vectors, Viral Particles
Citations:
(14)
Select up to 5 products from above to compare or request more information.
Showing 30 of 43513 products

Tags:

Please Login or Register to Create Tags
Addgene Inc.
51502-AAV9 | 100 µL
1
1 Figure from 29 Publications
Addgene Inc.
20298-AAV5 | 100 µL
3
2 Figures from 61 Publications
Addgene Inc.
44362-AAV8 | 100 µL
Extended Data  10
1 Figure from 97 Publications
Showing 3 of 3 products
  • <<
  • >>